(Q43679913)

25 November 2017

title

Strategies for aerosol therapy of alpha 1-antitrypsin deficiency by the aerosol route (English)

1 reference

alpha-1-antitrypsin deficiency

25 November 2017

1 reference

1 reference

R C Hubbard

1

1 reference

25 November 2017

R G Crystal

series ordinal

2

1 reference

25 November 2017

publication date

1 January 1990

1 reference

25 November 2017

1 reference

25 November 2017

volume

168 Suppl

1 reference

25 November 2017

page(s)

565-578

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02718179

25 November 2017

exact match

0 references

cites work

Molecular basis of alpha-1-antitrypsin deficiency

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02718179

Proteolytic Enzymes, their Inhibitors and Lung Diseases

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02718179

Alpha-1-antitrypsin augmentation therapy for alpha-1-antitrypsin deficiency

21 January 2018

1 reference

12 December 2020

Anti-neutrophil-elastase defenses of the lower respiratory tract in alpha 1-antitrypsin deficiency directly augmented with an aerosol of alpha 1-antitrypsin

1 reference

12 December 2020

Alpha 1 antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z. A survey by the British Thoracic Association

1 reference

12 December 2020

Fate of aerosolized recombinant DNA-produced alpha 1-antitrypsin: use of the epithelial surface of the lower respiratory tract to administer proteins of therapeutic importance

1 reference

12 December 2020

alpha1-antitrypsin deficiency (first of two parts).

1 reference

12 December 2020

Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase

1 reference

12 December 2020

Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema

1 reference

12 December 2020

Elastases and emphysema. Current assessment of the protease-antiprotease hypothesis

1 reference

12 December 2020

Biochemical efficacy and safety of monthly augmentation therapy for alpha 1-antitrypsin deficiency

1 reference

12 December 2020

Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase

1 reference

12 December 2020

Synthesis in E. coli of alpha 1-antitrypsin variants of therapeutic potential for emphysema and thrombosis.

1 reference

12 December 2020

Differential permeability of endothelial and epithelial barriers to albumin flux

1 reference

12 December 2020

Augmentation of lung antineutrophil elastase capacity with recombinant human alpha-1-antitrypsin

1 reference

12 December 2020

Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency

1 reference

12 December 2020

Long-term clearance of liquid and protein from the lungs of unanesthetized sheep

1 reference

12 December 2020

Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema

1 reference

12 December 2020

Production and administration to dogs of aerosols of alpha-1-proteinase inhibitor

1 reference

12 December 2020

Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin.

1 reference

12 December 2020

The alpha 1-antitrypsin gene and its mutations. Clinical consequences and strategies for therapy

1 reference

12 December 2020

Preparation and properties of alpha 1-proteinase inhibitor concentrate from human plasma

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02718179

1 reference

25 November 2017

1 reference